You are here: Industry Insights > perkinelmer

News List

Pharma industry reports 75 deals worth $26.6 billion in July 2021: GlobalData expresspharma
August 09, 2021
The industry also reported 112 venture capital (VC) deals worth $3.8 billion in the same month.
PerkinElmer agrees to acquire antibody maker BioLegend for $5.25bn pharmaceutical-technology
July 28, 2021
PerkinElmer has signed an agreement to acquire antibody and reagent maker BioLegend for nearly $5.25bn in cash and stock.
PerkinElmer Acquires Nexcelom Bioscience contractpharma
May 18, 2021
Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience americanpharmaceuticalreview
May 14, 2021
PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.
PerkinElmer to Acquire Cell Engineering Company Horizon Discovery americanpharmaceuticalreview
November 06, 2020
PerkinElmer and Horizon Discovery Group have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire Horizon for approximately $383 million (£296 million).
PerkinElmer to Acquire Horizon Discovery americanpharmaceuticalreview
November 04, 2020
PerkinElmer and Horizon Discovery Group have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire Horizon for approximately $383 million.
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing prnasia
March 25, 2020
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company's New Coronavirus RT-PCR test.
Shuwen Biotech to Offer Breakthrough Preeclampsia Detection Device Globally through Collaboration with PerkinElmer March 02, 2020
Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced that PerkinElmer, Inc. will distribute Shuwen’s breakthrough diagnostic test for preeclampsia in over 100 countries around the globe, accounting for over 120 million pregna
PerkinElmer to expand At Home health services biospectrumasia
July 28, 2019
PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market
PerkinElmer opens new manufacturing facility in Singapore biospectrumasia
May 09, 2019
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced the opening of a new office facility in Singapore.

Previous page 1 2 Next page